MedPath

Study on efficacy and safety of combination treatment with febuxostat and inosine for patients with heart failure

Not Applicable
Conditions
heart failure
Registration Number
JPRN-UMIN000025427
Lead Sponsor
Tsukuba International Clinical Pharmacology Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Not provided

Exclusion Criteria

1.Subject who has or had hypersensitivity, idiosyncracy (allergy) to drug. 2.Subjects taking azathioprine or mercaptopurine 3.Subject who has or had renal function disorder. 4.Subject with a history of gout, hyperuricemia or urolithiasis. 5.Patients who changed therapeutic drugs and treatment methods within 1 month before administration of test drugs 6.Subject who was judged not to be appropriate by the principal investigator or sub investigators by other reasons.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath